title: Is tamoxifen a risk factor for retinal vaso-occlusive disease?
authors.affiliation: Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. gorinmb@upmc.edu
authors.forename: Michael B
authors.initials: MB
authors.lastname: Gorin
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Costantino
authors.forename: Destan N
authors.initials: DN
authors.lastname: Kulacoglu
authors.forename: F Yesim K
authors.initials: FY
authors.lastname: Demirci
authors.forename: D Lawrence
authors.initials: DL
authors.lastname: Wickerham
authors.forename: Bernard
authors.initials: B
authors.lastname: Fisher
authors.forename: Norman
authors.initials: N
authors.lastname: Wolmark
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D015356:Retinal Artery Occlusion / Q000139:chemically induced*; D012170:Retinal Vein Occlusion / Q000139:chemically induced*; D012171:Retinal Vessels / Q000187:drug effects*; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects*; D013629:Tamoxifen / Q000009:adverse effects*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen